| EIEAX | FPGGX | EIEAX / FPGGX | |
| Total Expense Ratio | 0.94 | 0.43 | 219% |
| Annual Report Gross Expense Ratio | 1.46 | 0.43 | 340% |
| Fund Existence | 10 years | 5 years | - |
| Gain YTD | 12.131 | 20.008 | 61% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 860M | 24.9B | 3% |
| Annual Yield % from dividends | 0.31 | 0.61 | 52% |
| Returns for 1 year | 8.14 | 11.93 | 68% |
| Returns for 3 years | 53.13 | 54.38 | 98% |
| Returns for 5 years | 61.62 | 42.10 | 146% |
| Returns for 10 years | 138.47 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KCAI | 39.69 | 0.33 | +0.84% |
| KraneShares China Alpha Index ETF | |||
| FMED | 27.32 | 0.20 | +0.74% |
| Fidelity Disruptive Medicine ETF | |||
| RFV | 127.13 | 0.87 | +0.69% |
| Invesco S&P MidCap 400® Pure Value ETF | |||
| IBTI | 22.38 | -0.01 | -0.02% |
| iShares iBonds Dec 2028 Term Treasury ETF | |||
| PQJL | 28.62 | -0.05 | -0.18% |
| PGIM NASDAQ-100 BUFFER 12 ETF - JULY | |||